News ArchivesRead News
PD patients' surgery may conflict with medication
Thursday January 10, 2013
Nurse.com - Clinicians should carefully consider the scheduling of surgery for Parkinson’s disease patients to ensure optimal treatment with carbidopa-levodopa (Sinemet), the "gold-standard treatment" for PD, according to a study.
Researchers with the University of Minnesota School of Nursing and the university’s medical school conducted a study to establish clear guidelines regarding perioperative symptom management in PD patients, who may miss several doses of carbidopa-levodopa when put on NPO (nil per os, or nothing-by-mouth) status for surgery.
"One concern with carbidopa-levodopa is its short, one-to-two-hour half-life, requiring dosing several times per day," the researchers wrote in the January issue of the American Journal of Nursing
"Moreover, because of wide variability in patients’ responses to this and other antiparkinson medications, individual regimens may be quite complex. Some regimens require frequent administration, alternating short-acting and sustained-release doses of carbidopa-levodopa. The complex medication regimens are of particular concern when a patient with Parkinson’s disease must remain on NPO status for several hours postoperatively."
Kathleen Fagerlund, RN, PhD, Lisa Carney Anderson, PhD, and Olga Gurvich, MA, conducted a retrospective review of patient electronic health records at a Midwestern public medical center, finishing with a sample of 89 surgical events in 67 PD patients who had undergone any type of surgery aside from PD-related surgery and were taking carbidopa-levodopa.
They found the median duration of carbidopa-levodopa withholding was 12.35 hours — more than 16 hours for patients undergoing inpatient procedures and more than 11 hours for those undergoing outpatient procedures.
"Given the implications of prolonged withholding times on the therapeutic effects of carbidopa-levodopa, researchers and clinicians must ask how such times can be reduced," the authors wrote. "Operating room personnel, particularly certified registered nurse anesthetists, must be mindful that patients with Parkinson’s disease can take carbidopa-levodopa and other antiparkinson medications with a sip of water until shortly before the initiation of anesthesia; and in many cases these medications can be resumed in the postanesthesia recovery unit. In the presence of gastric discomfort, nausea or vomiting, an orally disintegrating preparation of carbidopa-levodopa could be considered."
Most surgical procedures began at 9 a.m. or later, with only 14% starting between 6 a.m. and 9 a.m. The most commonly reported exacerbation of PD symptoms was agitation or confusion.
The researchers concluded that for best symptom management, clinicians should schedule surgery on PD patients for as early in the day as possible, administer medications as close to the patient’s usual dosing schedule as possible and provide nursing education about optimal medication management for this patient population.
"Nurses can and should take the lead in ensuring that patients with Parkinson’s disease receive their medications on time, that disruptions to the regimen are minimized and that optimal symptom management is achieved," they wrote.
Recent NewsOct 18 - Fighting Parkinson's disease through dance
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show